Related Experiment Video
Updated: May 20, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
[Toll-like receptor 4: the potential therapeutic target for neuropathic pain]
Ze-jun Jia1, Fei-xiang Wu, Qing-hai Huang
1Department of Neurosurgery, Second Military Medical University, Shanghai, China.
Abstract:
Activation of microglia plays a vital role in the initiation and maintenance of specific neuropathic pain states. By activating microglia in central nervous system, Toll-like receptor 4 (TLR4) can promote the release of proinflammatory cytokines and neuroactive compounds, participate in the initiation and maintenance of neuropathic pain, and trigger the opiate side effects. Therefore, TLR4 may be a potential therapeutic target for neuropathic pain. Inhibition of TLR4 has shown some biological effects in neuropathic pain models and ibudilast (the TLR4 pathway-inhibiting agent) has been approved for for phase 2 clinical trials. This article briefly reviews the structure, function, and mechanism of TLR4 as well as the development of TLR4-targeted drugs.
Insights
Activation of microglia contributes to neuropathic pain. Toll-like receptor 4 (TLR4) is a key target, with inhibitors like ibudilast showing promise in clinical trials for pain management.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Context:
- Microglia activation is central to neuropathic pain development.
- Toll-like receptor 4 (TLR4) signaling in the central nervous system drives pain and opioid side effects.
Purpose:
- To review the structure, function, and mechanism of TLR4.
- To discuss the development of TLR4-targeted therapeutics for neuropathic pain.
Summary:
- TLR4 activation promotes pro-inflammatory cytokines and neuroactive compounds, contributing to neuropathic pain.
- Inhibiting TLR4 demonstrates therapeutic potential, with ibudilast advancing to Phase 2 clinical trials.
Impact:
- Highlights TLR4 as a viable therapeutic target for neuropathic pain.
- Informs drug development strategies for pain management by targeting the TLR4 pathway.
Related Concept Videos
Analgesia and Pain Management
Nociception
Opioid Receptors: Overview
Pain
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...